Citropten alleviates acute and recurrent colitis via blockage of NF-κB and JAK/STAT3 pathways
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.111102 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yu Zhen Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, PR China. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Fujian University of Traditional Chinese Medicine, Shanghai Municipal Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease, which is characterized by inflammation, with many symptoms including diarrhea, abdominal pain, bloody stool, and weight loss. It is difficult to completely cure and promising therapeutic drug candidates are urgently needed. Citropten, a coumarin-like compound found in traditional Chinese medicine such as Finger Citron Fruit, notopterygium root and citrus peel, has been shown to inhibit the proliferation of tumor cells, protect against depression and suppress the production of inflammatory mediators. In this study, we demonstrated that citropten could alleviate dextran sulfate sodium (DSS)-induced acute and recurrent colitis in mice, with significant improvement in body weight loss, disease activity index, shortened colon length and histological changes. Moreover, citropten dramatically decreased the production of pro-inflammatory mediators in colon tissues and effectively suppressed the proportion of Th17 cells in spleen. Mechanism investigations revealed that citropten significantly inhibited the activation of NF-κB and JAK/STAT3 signaling pathways, thus leading to decreased inflammation, Th17 cells and alleviative colitis. These findings provide novel insights into the anti-colitis effect of citropten, which may be a promising drug candidate for treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, PR China.
- Institute of Translational Medicine, Shanghai University, Shanghai 200444, PR China.
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, PR China; School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China.
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, PR China; School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China. Electronic address: jpzhang08@1…
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, PR China; School of Pharmacy, Second Military Medical University, Shanghai 200433, PR China. Electronic address: xuweiheng71…
Förderung
- Fujian University of Traditional Chinese Medicine
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Tang, Y. Z., Liu, Y., Chen, Y. P., Feng, T. T., Liu, Y. Y., Wang, Y., Zhang, J. P., & Xu, W. H. (2023). Citropten alleviates acute and recurrent colitis via blockage of NF-κB and JAK/STAT3 pathways. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111102
Vancouver
Tang YZ, Liu Y, Chen YP, Feng TT, Liu YY, Wang Y, et al. Citropten alleviates acute and recurrent colitis via blockage of NF-κB and JAK/STAT3 pathways. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.111102
BibTeX
@article{Tang2023,
author = {Tang, Yu Zhen and Liu, Ying and Chen, Ya Ping and Feng, Ting Ting and Liu, Ya Yi and Wang, Yan and Zhang, Jun Ping and Xu, Wei Heng},
title = {Citropten alleviates acute and recurrent colitis via blockage of NF-κB and JAK/STAT3 pathways},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.111102}
}
EUVIMED